Potential of ascorbic acid as antioxidant on chemotherapeutic agent induced change in morphology of testes

Aisha Abdul Haq1, Soofia Nigar1, Dureshewar Rehman2

  • 1Anatomy Department, Dow Medical College, DUHS, Karachi, Pakistan.

Abstract

Insights

Doxorubicin significantly reduced seminiferous tubule number and diameter in mice testes. Antioxidant vitamin C mitigated this damage, protecting testicular morphology.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Pharmacology

Background:

  • Anthracycline chemotherapy, such as doxorubicin, is crucial for cancer treatment.
  • Doxorubicin can induce significant side effects, including testicular toxicity.
  • Understanding doxorubicin's impact on male reproductive organs is vital for patient management.

Purpose of the Study:

  • To investigate the morphological changes in the number and diameter of seminiferous tubules in mouse testes following doxorubicin administration.
  • To evaluate the protective effect of vitamin C against doxorubicin-induced testicular damage.

Main Methods:

  • Male mice (5 weeks old) were divided into three groups: saline control, doxorubicin, and doxorubicin + vitamin C.
  • Testes were collected after sacrifice, processed, and stained for histological examination.
  • Statistical analysis was performed using SPSS 16.

Main Results:

  • Doxorubicin treatment significantly decreased the mean number and diameter of seminiferous tubules compared to the control group.
  • Mice treated with doxorubicin and vitamin C showed a significantly reduced damage to seminiferous tubules compared to the doxorubicin-only group.
  • The mean number of tubules in the doxorubicin group was 9.39±3.01, compared to 20.28±3.29 in controls and 18.56±2.82 in the vitamin C group.

Conclusions:

  • Doxorubicin induces significant morphological damage to mouse testes, affecting seminiferous tubule parameters.
  • The antioxidant vitamin C demonstrates a significant protective role in ameliorating doxorubicin-induced testicular toxicity.
  • Vitamin C co-administration is a promising strategy to mitigate chemotherapy-related reproductive side effects.